Science reveals the best exercise for knee arthritis relief

Summary

For people living with knee osteoarthritis, a common condition where the protective tissue in the joint wears down, finding daily relief is a major challenge. When your knees ache, moving around might be the last thing you want to do. However, a major review of 217 trials confirms that working out is actually a safe and essential part of treatment. In fact, getting your heart rate up with aerobic exercise is the most effective intervention for managing knee arthritis.

The research shows that accessible aerobic activities like walking, cycling, and swimming successfully reduce pain and improve physical movement, outperforming other types of workouts. This does not mean you should skip the weight room or your yoga mat. While strength training and mind-body exercises do offer real benefits, the researchers note that they are optimally used alongside a primary routine of aerobic exercise.

While the findings strongly support hitting the trail or the pool, there are a few caveats to keep in mind. Because this research is a high-level review of existing trials, it does not specify the underlying quality of the individual studies, exact patient sample sizes, or specific demographic details. Still, the overall message remains clear: consistent aerobic movement is a highly reliable strategy for protecting your knees.

Why it matters.

Knee arthritis affects a massive portion of the aging population, often leading to a frustrating cycle of inactivity, joint stiffness, and worsening pain. By pinpointing exactly which types of exercise work best, these findings give patients and doctors a clear, evidence-based roadmap for treatment. Instead of relying solely on pain medications or rushing toward joint replacement surgeries, doctors can confidently prescribe specific aerobic routines as a powerful primary treatment.

The beauty of this approach is that it relies on highly accessible, low-cost interventions. Activities like walking or swimming do not require expensive medical procedures or highly specialized clinic visits. By treating aerobic exercise as a core medical therapy, health care systems could potentially reduce treatment costs while empowering patients to take active control of their joint health and preserve their daily independence.

From the source

The story in numbers.

Clinical trials reviewed: 217
Specific aerobic activities highlighted (walking, cycling, swimming): 3

Keep the context

Follow the evidence.

This AI-assisted summary is a starting point. Read the original reporting for its methods, scope, and limitations.

Maryland sets a $274 monthly price cap on the diabetes drug Ozempic

The state of Maryland is taking a major step to rein in the cost of prescription medications. The Maryland Prescription Drug Affordability Board recently decided to set a strict price limit on Ozempic, a widely used treatment for type 2 diabetes. By establishing what is known as an upper payment limit, the board aims to make the medication more affordable for state budgets. Under this new rule, the cost of Ozempic will be capped at $274 for a standard 30-day supply. To come up with this number, the board looked at the maximum fair price that Medicare currently pays for the drug and used it as a benchmark. State officials estimate that this single price cap will save Maryland about $5.8 million every year. However, everyday consumers will not see these savings immediately. The initial price cap is slated to take effect in January 2027, and it will strictly apply to state and local government health plans. This means the immediate financial relief is limited to public programs rather than individual pharmacy visits for the general public.

STAT News1 min read

FDA shakeups, safety warnings, and a promising obesity pill

The Food and Drug Administration is navigating major leadership transitions, with acting directors Tracy Beth Høeg and Katherine Szarama recently exiting their roles in top drug review offices. Amidst these changes, the agency is facing severe safety concerns regarding Tavneos, a rare disease medication from the pharmaceutical company Amgen. In Japan, twenty patients taking the drug have died, with most of these deaths linked to a severe liver condition called vanishing bile duct syndrome. Following these tragedies and allegations of manipulated clinical trial data, the FDA has asked Amgen to withdraw the drug in the United States, though it currently remains available on the market. In other medical developments, an experimental daily pill for obesity is showing significant promise. Vincentage Pharma reported that patients taking its drug VCT220 in a late-stage Chinese clinical trial lost about twelve percent of their body weight over a year, compared to just one percent for those taking a placebo. However, the drug is still experimental globally, and a broader Phase 2 study is underway with results not expected until late 2026. Meanwhile, the major drugmaker Regeneron has teamed up with an early-stage startup called Parabilis Medicines. They plan to develop new therapies known as "antibody-helicon conjugates," which are designed to reach and treat disease-causing proteins inside cells that conventional methods have traditionally found impossible to target.

BioPharma Dive2 min read

Physical decline starts at 35, but late-in-life exercise boosts fitness

A massive study tracking people in Sweden for almost 50 years has pinpointed exactly when our bodies start to lose their physical edge. Researchers discovered that overall fitness, physical strength, and muscle endurance quietly begin to slip around age 35. Rather than maintaining a slow and steady pace, the researchers noted that the rate of this physical decline actually speeds up as the years go by. However, the study offers a highly encouraging twist for older adults. Even if someone has been inactive for decades, deciding to adopt a physically active lifestyle later in life can still yield major benefits. The researchers found that these late starters actually improved their physical performance by up to 10 percent, proving that the human body remains responsive to exercise well into old age. While tracking individuals over a five-decade span is a remarkable scientific achievement, there are a few limitations to keep in mind. The research is based entirely on a Swedish cohort, so it is unclear if these exact timelines apply to more diverse global populations. Additionally, the initial data does not specify the exact number of participants or the specific medical tests used to measure their fitness levels.

Science Daily1 min read

Follow your curiosity.

Science reveals the best exercise for knee arthritis relief

Summary

Why it matters.

The story in numbers.

Follow the evidence.

Your next discovery.

Maryland sets a $274 monthly price cap on the diabetes drug Ozempic

FDA shakeups, safety warnings, and a promising obesity pill

Physical decline starts at 35, but late-in-life exercise boosts fitness

Summary

Why it matters.

The story in numbers.

Follow the evidence.

Your next discovery.

Maryland sets a $274 monthly price cap on the diabetes drug Ozempic

FDA shakeups, safety warnings, and a promising obesity pill

Physical decline starts at 35, but late-in-life exercise boosts fitness

A little science goes a long way.